Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15837-15844
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15837
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15837
Parameter | Diarrhea | No diarrhea | P value |
n | 12 | 48 | |
Age (yr) | 80.3 ± 13.4 | 69.8 ± 18 | 0.019 |
Gender | M: 21.6%F:17.4% | M: 78.4%F: 82.6% | NS |
Hospital stay (d) | 19.3 ± 10.9 | 9.3 ± 5.2 | < 0.001 |
Creatinine (mg/dL) | 1.2 ± 0.4 | 1.1 ± 0.4 | NS |
Albumine (mg/dL) | 3.3 ± 0.5 | 3.6 ± 0.4 | < 0.001 |
BMI | 24.0 ± 4.0 | 25.9 ± 4.1 | NS |
Concurrent PPI treat. | 75.0% | 27.1% | 0.005 |
Antibiotic treatment in history | 33.3% | 0.0% | 0.001 |
-
Citation: Dietrich CG, Kottmann T, Alavi M. Commercially available probiotic drinks containing
Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea. World J Gastroenterol 2014; 20(42): 15837-15844 - URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15837.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15837